Repurposing flubendazole for glioblastoma ferroptosis by affecting xCT and TFRC proteins
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Wei Teng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Mebendazole, Glioblastoma, Drug Repositioning. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guizhou Province Science and Technology Plan Project (Project), National Natural Science Foundation of China (NSFC), Affiliated Hospital of Guizhou Medical University, Guizhou Science and Technology Plan Project.
Abstract (Originalsprache)
New uses of old drugs hold great promise for clinical translation. Flubendazole, an FDA‐approved antiparasitic drug, has been shown to target p53 and promote apoptosis in glioblastoma (GBM) cells. However, its damaging mechanism in GBM remains elusive. Herein, we explored the ferroptosis‐inducing ability of flubendazole on GBM cells. After treating glioma cell lines U251 and LN229 with the flubendazole (DMSO
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Clinical Medicine, Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Neurosurgery, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
ORCID-Profile: Liangzhao Chu
Förderung
- Guizhou Province Science and Technology Plan Project (Project)
- National Natural Science Foundation of China (NSFC), Affiliated Hospital of Guizhou Medical University
- Guizhou Science and Technology Plan Project
- National Natural Science Foundation of China
- Science and Technology Fund project of Guizhou Provincial Health Commission
Zitieren
APA
Teng, W., Ling, Y., Long, N., Cen, W., Zhang, H., Jiang, L., Liu, J., Zhou, X., & Chu, L. (2024). Repurposing flubendazole for glioblastoma ferroptosis by affecting xCT and TFRC proteins. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70188
Vancouver
Teng W, Ling Y, Long N, Cen W, Zhang H, Jiang L, et al. Repurposing flubendazole for glioblastoma ferroptosis by affecting xCT and TFRC proteins. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70188
BibTeX
@article{Teng2024,
author = {Teng, Wei and Ling, Yuanguo and Long, Niya and Cen, Wu and Zhang, Hongzhi and Jiang, Lishi and Liu, Jian and Zhou, Xingwang and Chu, Liangzhao},
title = {Repurposing flubendazole for glioblastoma ferroptosis by affecting xCT and TFRC proteins},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70188}
}
EUVIMED